One-Time cell therapy tested for patients out of options
NCT ID NCT03642626
Summary
This study is testing several already FDA-approved CAR-T cell therapies for people with blood cancers that have come back or not responded to other treatments. It aims to see how well these one-time infusions work and how safe they are for different groups of patients, including children and adults with leukemia or lymphoma. The main goal is to measure the rate of cancer remission and monitor for serious side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.